Navigation Links
FDA approves Bystolic, a novel beta blocker
Date:12/18/2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...IGHTS, Mich., Dec. 4 The Editorial...erInvesting Magazine today announced Allergan, I... Study" and C.R. Bard, Inc. (NYSE: BCR ) as it... informational and educational use. ,, "The com...ies involving its flagship drug Botox and other pr...
(Date:12/4/2009)...4 While Congress debate...care costs, Leapfrog,s purchaser members point to ...ng the best quality care in the nation while attai... urban, eight children,s and three rural hospitals...d on results from The Leapfrog Hospital Survey. ,...
(Date:12/4/2009)... some pediatric cancers, particularly Ewing sarcom...ding to a new study published online December 4 in..., This study was undertaken because there is limi... up to 20 years) for pediatric cancer patients. ,...er Center and Blood Disorders Service, Children,s ...
(Date:12/4/2009)...ts at Johns Hopkins publishing in the December iss...y a gene called "Twist" may be the proverbial red ...at drive aggressive, metastatic breast cancer from... work suggesting that it is a relatively rare subg...east cancer, scientists have surmised that this su...
(Date:12/4/2009)...ans are recruited annually to participate in clini...earch Protection (AHRP), and most will be compensa...itutions view payments to volunteers as compensati...potential risks related to participating in the ex...have a very different view of clinical trial compe...
Breaking Medicine News(10 mins):Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Human guinea pigs wary of high-paying medical trials 2
... Sept. 5 Traditional Latin,American foods have a ...,many of these foods that have brought families to...ays that can compromise one,s health. Oftentimes ..., eating foods high in fat and calories can place ...
...ember 4, 2007) Today, the Canadian Institutes of ...omote public access to the results of research it ...nsure that their original research articles are fr... is essential for advancing knowledge and accelera...
... TriWest Healthcare Alliance is,offering an innov...families,who have lost a loved one in service to o...ard and Reserve unit commanders, TriWest is partne...s-kind partnership, TriWest and Steen will offer,"...
...t. 4 HEI, Inc. (Nasdaq: HEII,-- http://www.heii....le of,substantially all of the assets of its RFID ...-owned subsidiary of Dutch based Smartrac N.V. The...mer lists, and the assumption of substantially all...
...e Technology Executive Brings Over 20 Years Of Exp...ional Excellence, LENEXA, Kan., Sept. 4 /PRNewswi..., (Nasdaq: MEDW ) announced the appointment of Th...y,division where he held a wide range of senior ma...
...y Jeremy Graff and colleagues from Eli Lilly and C...a new therapeutic in a mouse model of human tumors...ty of this therapeutic to treat human cancers. As ... effective in clinical trials as it was in mice it...
Other Medicine News:Health News:Top Tips to Enjoy Healthy Latin Food Without Losing the Taste (Recipe) 2Health News:Top Tips to Enjoy Healthy Latin Food Without Losing the Taste (Recipe) 3Health News:Open access to health research publications 2Health News:TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program 2Health News:HEI, Inc. Closes on Sale of RFID Division Assets 2Health News:Mediware Names Thomas K. Mann Chief Executive Officer 2Health News:It's a knock out: eIF4E-specific anti-sense oligonucleotides knock down cancer 2
(Date:12/4/2009)..., , DURHAM, N.C., Dec. 4 /PRNewswire-FirstCal...oard: OXBT) today announced that the first patient...se escalation, clinical trial in Switzerland for u...ry (TBI). Oxycyte is the Company,s perfluorocarbon...al is of invaluable importance in improving the ou...
(Date:12/4/2009)..., , ANNAPOLIS, Md., Dec. 4 /PRNewswire-Firs...biodefense company developing medical countermeasu...nced today the presentation of new data from the C...lyophilized recombinant Protective Antigen (rPA) b...tent after 16 months at various temperatures up to...
(Date:12/4/2009)..., , Opposes use of imported drugs often sto... Dec. 4 Today, the seni...efeat the Dorgan Importation plan encompassed in S..."Senator Dorgan,s importation amendment is poised ...g system to be breached, and our health to be enda...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5RetireSafe Urges Senate to Defeat Senate Amendment 2793 -- Says Senator Dorgan's Drug Importation Plan Puts Seniors at Risk 2Free Compirion Bed Flow Webinar Helps Improve Patient Flow From ED to Inpatient Units 54747 1Free Compirion Bed Flow Webinar Helps Improve Patient Flow From ED to Inpatient Units 54747 2Free Compirion Bed Flow Webinar Helps Improve Patient Flow From ED to Inpatient Units 54747 3Thomson Reuters Joins the InChI Trust 13612 1Thomson Reuters Joins the InChI Trust 13612 27 Easy Tips for Healthy Aging 54745 17 Easy Tips for Healthy Aging 54745 2
...et, Inc. (Nasdaq:,MITI), a biopharmaceutical compa...e treatment of cancer, inflammation and autoimmune...1) showing cytotoxic activity of,anti-EpCAM antibo... colon,cancer cells on November 1, 2008 at the 23r...Biological Therapy of Cancer (iSBTc) , taking,plac...
...ionovo, Inc.,(Nasdaq: BNVI ) announced today that...BZL101, will advance to Phase 2 clinical testing a... clinical trial., The Phase 1B clinical trial was...of BZL101 and to determine the safety and feasibil...ment. A total of 27 women with,metastatic breast c...
Other Medicine Technology:Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells 2Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells 3Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells 4Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells 5Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer 2Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer 3Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer 4
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
Medicine Products: